Enlivex Therapeutics Ltd. (ENLV) shares are sliding more than 12 percent on Wednesday morning, despite no specific announcement from the company.
Currently, the shares are at $12.71, down 12.31 percent from its previous close of $14.50. The shares have traded in a range of $3.59 to $16.94 on average volume of 962,601.
The clinical-stage immunotherapy company had reported positive results for its investigator-initiated clinical trial of Allocetra in COVID-19 patients in severe or critical condition on October 1. The shares have been trading higher since then, however, started to slide this morning
For comments and feedback contact: editorial@rttnews.com
